Impact of IIT-SIT on Dengue Clusters
NCT06894901 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 900
Last updated 2025-03-25
Summary
This randomized controlled trial aims to evaluate the efficacy of Wolbachia-infected male mosquitoes combined with sterile insect technique (IIT-SIT) to mitigate active dengue transmission in Singapore.
Conditions
- Dengue
Interventions
- BIOLOGICAL
-
Biological (Male Wolbachia-infected Aedes aegypti)
Releases of male Wolbachia-infected Aedes aegypti mosquitoes
Sponsors & Collaborators
-
Ministry of Health, Singapore
collaborator OTHER_GOV -
National Environment Agency, Singapore
lead OTHER_GOV
Principal Investigators
-
Lee Ching Ng Group Director (Environmental Health Institute), PhD · Environmental Health Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-20
- Primary Completion
- 2027-07-20
- Completion
- 2028-01-20
Countries
- Singapore
Study Locations
More Related Trials
-
Immuno-epidemiological and Socio-behavioral Evaluation of Release of Sterile Male Aedes Albopictus Mosquitoes on Human-vector Contacts
NCT05313126 ·Status: UNKNOWN ·Phase: NA
-
Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in Children
NCT03534245 ·Status: COMPLETED
-
Implementation Research of New Dengue Vector Control Tools
NCT00883441 ·Status: COMPLETED ·Phase: NA
-
Effect of Ivermectin Metabolites on Mosquito Survival
NCT03690453 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia
NCT03631719 ·Status: COMPLETED
-
A Clinical Study to Develop an Uninfected Sand Fly Biting Protocol
NCT03999970 ·Status: COMPLETED ·Phase: NA
-
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
NCT03641339 ·Status: COMPLETED ·Phase: NA
-
Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine
NCT02406729 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨
NCT02687971 ·Status: COMPLETED ·Phase: PHASE2
-
High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients
NCT07094724 ·Status: RECRUITING ·Phase: PHASE2
-
Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore
NCT02569827 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Duration of Immunity 10 Years After a Dose-response Study With Yellow Fever Vaccine - Complementary Study
NCT04416477 ·Status: UNKNOWN
-
Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World
NCT04515186 ·Status: COMPLETED ·Phase: PHASE3
-
EaveTubes for Vector Control
NCT05736679 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis
NCT07149753 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Virological and Immunological Determinants of Arbovirus Infection in New Caledonia
NCT04619823 ·Status: RECRUITING ·Phase: NA
-
World Mosquito Program Noumea - Human Sample Component
NCT03552094 ·Status: UNKNOWN
-
ARBOspot: Characterization of Arbovirus Specific T Cell Response in Patients by Using Enzyme Linked Immunospot (ELISpot) Assays
NCT07291206 ·Status: RECRUITING
-
Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa
NCT01067443 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Safety and Immunogenicity of AGS-v PLUS, a Universal Mosquito-Borne Disease and Mosquito Control Vaccine
NCT04009824 ·Status: COMPLETED ·Phase: PHASE1
-
Dengue Vaccine Hesitancy and Acceptance in Endemic Regions of Argentina: Impact of Communication Strategies
NCT05213364 ·Status: UNKNOWN
-
Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis
NCT01301924 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of Dengue Vaccine in Healthy Children, Teenagers and Adults in India
NCT06060067 ·Status: COMPLETED ·Phase: PHASE3
-
Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
NCT02429518 ·Status: COMPLETED
-
Safety, Attenuation and Immunogenicity of GAP3KO Administered Via A Stephensi Mosquitoes
NCT02313376 ·Status: COMPLETED ·Phase: PHASE1